机构:[1]Department of Blood Transfusion, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.医技科室输血科河北医科大学第四医院[2]Clinical Laboratory, Yantai Central Blood Station, Yantai, Shandong, China.[3]Department of Quality Control and Laboratory, Yantai Central Blood Station, Yantai, Shandong, China.[4]College of Nursing, Hebei Medical University, Shijiazhuang, Hebei, China.
Blood transfusion treatment is one of the important means to rescue critically ill patients, while actively searching for the cause of bleeding, it is necessary to choose a reasonable transfusion treatment plan. For patients who need to receive blood transfusion treatment, their etiology is different, treatment methods are different, and clinical manifestations are different. The principle of blood transfusion treatment is to eliminate the cause, timely hemostasis, and transfusion is decided according to the actual condition of the patient to replenish the blood volume in time. Blood transfusion treatment has certain risks, it is necessary to make adequate preparations before blood transfusion, improve the safety of blood transfusion, and reduce the probability of infectious diseases caused by blood transfusion treatment to a certain extent, and carry out certain tests for patients who need blood transfusion treatment. The hepatitis B surface antigen, immunodeficiency virus antibodies, hepatitis c virus antibodies and syphilis of patients are tested to find potential sources of infection in time, reduce infections caused by blood transfusion, and reduce medical disputes caused by it.
基金:
Health and Family Planning commission of Hebei Province, china (Study on red blood cell recovery of cancer patients by irradiation combined with filter No. 20150350 and 20211424).
语种:
外文
WOS:
PubmedID:
中科院分区:
出版当年[2025]版:
大类|4 区医学
小类|4 区医学:内科
最新[2025]版:
大类|4 区医学
小类|4 区医学:内科
第一作者:
第一作者机构:[1]Department of Blood Transfusion, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
通讯作者:
推荐引用方式(GB/T 7714):
Ren Xiaoliang,Zhuang Hui,Guo Nan,et al.Analysis of the detection of transfusion-related infectious diseases in blood recipients before transfusion[J].Minerva Medica.2024,doi:10.23736/S0026-4806.24.09176-6.
APA:
Ren Xiaoliang,Zhuang Hui,Guo Nan&Wang Bingshuang.(2024).Analysis of the detection of transfusion-related infectious diseases in blood recipients before transfusion.Minerva Medica,,
MLA:
Ren Xiaoliang,et al."Analysis of the detection of transfusion-related infectious diseases in blood recipients before transfusion".Minerva Medica .(2024)